News We’re Watching: Free COVID-19 Tests, Edwards Antitrust Investigation, McKinsey Calls For Medtech ‘Reinvention’

This week, the US government relaunched a program providing free COVID-19 tests and invested $600m in domestic test manufacturing; the European Commission revealed an antitrust investigation of Edwards LifeSciences; and a consulting firm report said the medtech industry should make big changes to address investor skepticism.

"News We're Watching" Feature Image
• Source: Medtech Insight

With COVID-19 cases ticking back up, the Biden administration is restarting a program that allows Americans to get four rapid tests in the mail at no charge. The tests can be ordered now at COVID.gov and will be delivered by the US Postal Service beginning 2 October.

Along with announcing the program’s relaunch, the administration also announced that it was investing $600m across 12 domestic test...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation